The Gastrointestinal Research Foundation (GIRF) has launched a new initiative, CA CURE, to identify and fund research to improve diagnostics and develop therapeutics focused on immunotherapies and personalized vaccines for digestive cancers, with a focus on projects that might have difficulty attracting funds because they are too experimental or are in the initial stages of development.